FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

US Compounding MedroxyPROGESTERone/Lidocaine Recall

MedroxyPROGESTERone/Lidocaine (150 mg/mL/1%) 10 mL Multi-Dose Vial, For IM Injection On…

US Compounding Inc · Conway, AR

Risk level
Class II
Reported by FDA
Nov 25, 2015
Recall ID
D-0263-2016
Check your lot numberHow we source this data

Summary

US Compounding recalled MedroxyPROGESTERone/Lidocaine starting Sep 12, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0263-2016 on Nov 25, 2015. Reason: Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Product description

MedroxyPROGESTERone/Lidocaine (150 mg/mL/1%) 10 mL Multi-Dose Vial, For IM Injection Only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3113-07

Lot numbers, UPCs & expiration codes

Lot Numbers: 20150705@13 BUD: 11/3/2015, 20151805@36 BUD: 11/14/2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0263-2016
Classification
Class II
Status
Terminated
Recall initiated
Sep 12, 2015
FDA report date
Nov 25, 2015
Quantity
439 vials
Recall type
Voluntary: Firm initiated
Recalling firm
US Compounding Inc

Original FDA data

Every field from FDA enforcement report D-0263-2016, exactly as published.

Show all FDA fields
City
Conway
State
AR
Status
Terminated
Country
United States
Event ID
72179
Address
1270 Don's Lane
Code information
Lot Numbers: 20150705@13 BUD: 11/3/2015, 20151805@36 BUD: 11/14/2015
Postal code
72032
Report date
Nov 25, 2015
Product type
Drugs
Recall number
D-0263-2016
Classification
Class II
Recalling firm
US Compounding Inc
Product quantity
439 vials
Termination date
Mar 30, 2017
Reason for recall
Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
MedroxyPROGESTERone/Lidocaine (150 mg/mL/1%) 10 mL Multi-Dose Vial, For IM Injection Only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3113-07
Distribution pattern
Nationwide
Recall initiation date
Sep 12, 2015
Initial firm notification
Letter
Center classification date
Nov 17, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0263-2016, published Nov 25, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls